semaglutide glp 1 for weight loss GLP-1s Novo Nordisk Drops Hims &

Zuraikat FM, Makarem N, Redline S, Aggarwal B, Jelic S, St-Onge MP (2020) Sleep regularity and cardiometabolic heath: is variability in sleep patterns a risk factor for excess adiposity and glycemic dysregulation

doi:10.1111/j.1463-1326.2012.01663.x 17

Neurodegeneration and PD models The neuroprotection of GLP-1RAs has also been tested in in vivo models of PD, the second most common neurodegenerative disease

This discovery eventually led to the use of certain GLP-1 medications as part of medically supervised weight management programmes and obesity treatment

95% CI, 0.44 to 1.12

Rapid weight loss, a common effect of GLP-1 use, can result in decreased bone density, heightening the risk of osteoporosis and fractures